ERBB2 and breast cancer: BC is identified based on the immunohistochemical measures of estrogen receptor (ER), antigen Ki-67 (Ki-67), human epidermal growth factor receptor 2 (HER2), and progesterone receptor (PR) (Cuzick et al. 2011).